Triumph Foundation Blog

UCLA Bladder Study

March 22, 2017

This study is looking at the effects of non-invasive transcutaneous magnetic stimulation on DSD (detrusor-sphincter dyssynergia). Overall the study will look at whether this intervention helps to improve volitional urination and decrease frequency of catheterization. The treatment will be twice a week at UCLA for approximately 1 year. Several people that we’ve talked to don’t know if they truly have DSD (sometimes called a neurogenic bladder), which is fine. If they have the symptoms of not being able to volitionally void due to increased urethral pressure, then we’ll perform a video urodynamics study to confirm DSD prior to the beginning of the study.

Inclusion Criteria:

1.     Male

2.     Age 18-75

3.     At least 1 year post injury

4.     Non-progressive SCI at C2-T8

5.     ASIA A-B

6.     Neurogenic Bladder requiring CISC (clean intermittent self-catheterization)

Exclusion Criteria:

1.     History of autonomic dysreflexia

2.     Ventilator dependency

3.     Musculoskeletal dysfunction (current fracture or infection)

4.     Clinically significant depression

5.     Ongoing drug abuse

6.     Received Botox injection

7.     Previous bladder surgery

8.     Significant cardiopulmonary disease

For more information contact Josh Chambers JChambers@mednet.ucla.edu

0 Comments

No comments posted. Be the first to post a comment.

Post Your Comments

*Name


*Email


Website


*Comments:


*Type the letters in the box below: